$AUNA

Auna S.A. Q2 2026 Earnings Call Summary

Auna S.A. reported Q2 2026 revenue growth of 9%, driven by high-complexity services, with adjusted EBITDA declining 9% due to investment costs. Management reaffirmed full-year revenue guidance of 12% growth and expects EBITDA growth at the low end of 10-14%. Free cash flow increased 181% due to working capital management. The company faces short-term penalties in Peru but anticipates improvements in profitability and cash flow.

Original reporting
Published Aug 20, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Auna S.A. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$AUNANeutralMed
01

Why it matters

Earnings release provides fresh financial metrics and guidance, influencing investor expectations.

02

Market read

First report of Q2 results and FY guidance; material for investors in emerging‑market healthcare.

03

What to watch

FX hedge reset benefits and new ICU capacity additions may improve cash flow beyond current guidance.

Relevance 7/10Novelty 7/10Timing: post-earnings Q2 2026 release

Background

Auna S.A. provides integrated health services across Mexico, Colombia, and Peru, listed on NYSE.

Company-level read

Ticker impact

$AUNANeutralMedium confidence
Context

Q2 2026 earnings release with revenue growth, adjusted EBITDA decline, and updated full-year guidance.

Expected impact

Potential short-term price dip on margin decline, long-term support from reaffirmed revenue guidance.

Evidence & confidence

Guidance confirms growth trajectory; however, EBITDA contraction and penalties may weigh on valuation.

Market effects

Highlights recovery trends in Latin American healthcare services and risk‑sharing contracts.

Positive signal for Mexico and Colombia health markets; Peru penalties may temper local sentiment.

Limited to emerging‑market health sector investors.

Counterpoint

Margin pressures and billing penalties could signal deeper operational issues, suggesting a sell stance.

Key entities

  • Auna S.A.

    Latin American health services provider.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,

$AUNAMedAI 9/10

Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q2 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea

$NKEHighAI 9/10

Nike (NKE) shares fell 8.7% in after-hours trading after reporting weaker-than-expected Q1 results and announcing restructuring plans

Nike (NKE) shares fell 8.7% in after-hours trading after reporting weaker-than-expected Q1 results and announcing restructuring plans. Revenue declined 4% to $11.21B, missing estimates, while net income dropped 2% to $712M. The company forecasted a high-single-digit percentage decline in full-year revenue for fiscal 2027, steeper than market projections. China's market revenue plunged 26%, marking nine consecutive quarters of decline.